What should you know about targeted chemotherapy for ovarian cancer?

The oncology team may review the tumour under a microscope and use genomic tumour profiling to look for changes that influence treatment. BRCA genetic testing can provide separate information about inherited risk and may also affect treatment discussions. Targeted medicines can be used alone or alongside chemotherapy, surgery or other care, depending on the tumour, its spread, previous treatment and the person's health.

Treatment may be delivered by infusion or tablet. Possible effects vary by medicine and can include tiredness, nausea, bowel changes, blood-count changes, skin symptoms or effects on organs. Monitoring usually combines symptom review with blood tests and imaging when appropriate.

Ask what each test is looking for and whether a result comes from the tumour or from inherited genetic information. Give the team a complete list of medicines and supplements. Keep a record of doses and symptoms, and ask before taking non-prescribed remedies. Discuss fertility, menstrual changes, contraception and pregnancy plans before treatment if these are relevant to you.

Contact the treatment team promptly for fever, persistent vomiting, severe diarrhoea, unusual bruising, heavy bleeding, worsening abdominal swelling, reduced urine or a new severe rash. Seek urgent help for breathing difficulty, collapse, confusion or severe pain. Do not wait for the next appointment when a symptom is rapidly worsening.

Which tumour feature supports this medicine? Should I have BRCA genetic testing as well as tumour testing? How will surgery or chemotherapy fit around it? Which side effects need urgent review, and how might treatment affect fertility or pregnancy?